OrbiMed
General contacts
Investor type
PE / VC
Founded
1989
AUM
$20 000 M
Location
New York, New York, United States
Investor profile last updated: 06 June, 2026
Profile
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Industry
OrbiMed Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
OrbiMed Private Investments VIII
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Seed
|
North America
Asia
|
$5-10 m
|
$1500 M
|
March 2025
|
|
OrbiMed Asia Partners V
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
HealthTech
|
Seed
|
North America
Asia
|
$5-10 m
|
$751 M
|
October 2023
|
|
OrbiMed Private Investments IX
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Media and Entertainment
SaaS
Security
Software
HealthTech
|
Series B
|
North America
Europe
Asia
|
$5-10 m
|
$1900 M
|
October 2023
|
|
OrbiMed Royalty and Credit Opportunities Fund V
|
Fund of funds
|
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
HealthTech
|
Seed
Series A
Series B
|
North America
Middle East
Asia
|
$5-10 m
|
$1900 M
|
August 2025
|
|
OrbiMed Royalty and Credit Opportunities IV
|
Fund of funds
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
SaaS
Security
Software
HealthTech
|
Seed
Series A
Series B
|
North America
Europe
Asia
|
$5-10 m
|
$1700 M
|
October 2023
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for OrbiMed — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about OrbiMed
Is OrbiMed a venture capital or private equity firm?
OrbiMed is a venture capital and private equity firm. It backs companies at Seed, Pre-seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Where is OrbiMed located?
OrbiMed is located in New York, New York, United States.
When was OrbiMed founded?
OrbiMed was founded in 1989.
What sectors and industries does OrbiMed invest in?
OrbiMed invests in companies and startups in Software, Security, SaaS, Pharmaceuticals, Other, Medical Devices, Healthcare Services, Biotechnology, MedTech, Life Sciences, HealthTech, Food and Beverage, Foodtech, Media and Entertainment, Marketing and Advertising.
What is OrbiMed geographical focus of investments?
OrbiMed invests in companies and startups in North America, South America, Europe, Middle East, Africa, Asia, Australia and others.
At what stages of companies and startups does OrbiMed typically invest in?
OrbiMed invests in companies and startups at Seed, Pre-seed, Series A, Series B, Late Stage (Series C+).
What is the usual amount of OrbiMed investment?
OrbiMed usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for OrbiMed?
OrbiMed has around $20 000m assets under management.
When was OrbiMed last fund created?
OrbiMed last fund was created/launched in 2026-06-02
What are the contacts of OrbiMed?
OrbiMed can be reached through its website orbimed.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for OrbiMed — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access OrbiMed data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query OrbiMed directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the OrbiMed profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 06 June, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.